These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 24471823

  • 1. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K, Sistla R, Shastri NR.
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [Abstract] [Full Text] [Related]

  • 2. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
    Galal S, El Massik MA, Abdallah OY, Daabis NA.
    Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
    [Abstract] [Full Text] [Related]

  • 3. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.
    Alladi S, Shastri NR.
    Arch Pharm Res; 2015 Sep; 38(5):801-12. PubMed ID: 24752862
    [Abstract] [Full Text] [Related]

  • 4. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.
    Vasvári G, Csontos B, Sovány T, Regdon G, Bényei A, Váradi J, Bácskay I, Ujhelyi Z, Fehér P, Sinka D, Nguyen TLP, Vecsernyés M, Fenyvesi F.
    AAPS PharmSciTech; 2018 Oct; 19(7):3165-3176. PubMed ID: 30136176
    [Abstract] [Full Text] [Related]

  • 5. Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography.
    Sharma P, Pathak K.
    AAPS PharmSciTech; 2013 Jun; 14(2):736-47. PubMed ID: 23615771
    [Abstract] [Full Text] [Related]

  • 6. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D, Sailaja Chirravuri SV, Shastri NR.
    Int J Pharm; 2014 Jan 30; 461(1-2):459-68. PubMed ID: 24368106
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A, El-Menshawe S, Afouna M.
    Pharmazie; 2012 Mar 30; 67(3):209-14. PubMed ID: 22530301
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance.
    Schamp K, Schreder SA, Dressman J.
    Eur J Pharm Biopharm; 2006 Apr 30; 62(3):227-34. PubMed ID: 16246538
    [Abstract] [Full Text] [Related]

  • 12. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
    Mathurm M, Gilhotra RM.
    Drug Deliv; 2011 Jan 30; 18(1):54-64. PubMed ID: 20718601
    [Abstract] [Full Text] [Related]

  • 13. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
    Mutalik S, Manoj K, Reddy MS, Kushtagi P, Usha AN, Anju P, Ranjith AK, Udupa N.
    AAPS PharmSciTech; 2008 Jan 30; 9(2):651-9. PubMed ID: 18500561
    [Abstract] [Full Text] [Related]

  • 14. Semisolid matrix filled capsules: an approach to improve dissolution stability of phenytoin sodium formulation.
    El Massik MA, Abdallah OY, Galal S, Daabis NA.
    Drug Dev Ind Pharm; 2003 May 30; 29(5):531-43. PubMed ID: 12779283
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of diclofenac sodium sustained release matrix pellets: impact of polyethylene glycols molecular weight.
    Ibrahim A, Shazly A.
    Acta Pol Pharm; 2014 May 30; 71(5):821-31. PubMed ID: 25362811
    [Abstract] [Full Text] [Related]

  • 16. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
    Dasgupta S, Ghosh SK, Ray S, Mazumder B.
    Curr Drug Deliv; 2013 Dec 30; 10(6):656-66. PubMed ID: 24274634
    [Abstract] [Full Text] [Related]

  • 17. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA, Danopoulos P, Demirdjian L, Nogueira RJ, Dubois F.
    Int J Pharm Compd; 2013 Dec 30; 17(5):424-31. PubMed ID: 24459788
    [Abstract] [Full Text] [Related]

  • 18. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
    Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, Anju P, Prasanna S.
    Arch Pharm Res; 2007 Feb 30; 30(2):222-34. PubMed ID: 17366745
    [Abstract] [Full Text] [Related]

  • 19. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH, Taha NF, Badr RM, Mursi NM.
    Drug Discov Ther; 2012 Oct 30; 6(5):269-77. PubMed ID: 23229148
    [Abstract] [Full Text] [Related]

  • 20. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N, Tadikonda R.
    Drug Dev Ind Pharm; 2015 Jun 30; 41(6):888-97. PubMed ID: 24796274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.